Cannell Capital LLC Neuronetics, Inc. Transaction History

Cannell Capital LLC

$434 Million
Q3 2024

A detailed history of Cannell Capital LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cannell Capital LLC holds 1,314,266 shares of STIM stock, worth $1.73 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,314,266

Previous 2,381,303 44.81%

Holding current value

$1.73 Million

Previous $4.29 Million 76.71%

% of portfolio

0.23%

Previous 1.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.73 - $2.0 $778,937 - $2.13 Million	-1,067,037 Reduced 44.81%	1,314,266 $998,000
Q2 2024 Aug 13, 2024	SELL	$1.73 - $4.81 $141,778 - $394,193	-81,953 Reduced 3.33%	2,381,303 $4.29 Million
Q1 2024 May 14, 2024	SELL	$2.68 - $4.8 $820,112 - $1.47 Million	-306,012 Reduced 11.05%	2,463,256 $11.7 Million
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $67,949 - $187,670	-64,714 Reduced 2.28%	2,769,268 $8.03 Million
Q3 2023 Nov 14, 2023	BUY	$1.29 - $2.22 $84,159 - $144,832	65,240 Added 2.36%	2,833,982 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $743,289 - $1.05 Million	-359,077 Reduced 11.48%	2,768,742 $5.95 Million
Q1 2023 May 15, 2023	SELL	$2.81 - $6.71 $332,456 - $793,873	-118,312 Reduced 3.64%	3,127,819 $9.1 Million
Q4 2022 Feb 14, 2023	SELL	$2.74 - $6.87 $596,539 - $1.5 Million	-217,715 Reduced 6.29%	3,246,131 $22.3 Million
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $1.49 Million - $2.65 Million	713,493 Added 25.94%	3,463,846 $11.1 Million
Q1 2022 May 17, 2022	BUY	$2.84 - $4.52 $335,492 - $533,952	118,131 Added 4.49%	2,750,353 $8.33 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $2.12 Million - $3.61 Million	547,219 Added 26.25%	2,632,222 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $4.81 Million - $12 Million	772,665 Added 58.88%	2,085,003 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $12.7 Million - $21.5 Million	1,248,029 Added 1940.68%	1,312,338 $21 Million
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $681,675 - $1.37 Million	64,309 New	64,309 $796,000
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $1.12 Million - $2.59 Million	-226,423 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $412,089 - $1.33 Million	226,423 New	226,423 $1.1 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $35.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannell Capital LLC with notifications on news.

Account

Cannell Capital LLC Neuronetics, Inc. Transaction History